Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01752920
Title Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArQule
Indications

Advanced Solid Tumor

Therapies

Derazantinib

Age Groups: adult
Covered Countries USA | ITA


No variant requirements are available.